+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Compound heterozygosity for two GHR missense mutations in a patient affected by Laron Syndrome: a case report



Compound heterozygosity for two GHR missense mutations in a patient affected by Laron Syndrome: a case report



Italian Journal of Pediatrics 43(1): 94



Mutations localized in the Growth Hormone Receptor (GHR) gene are often associated with the pathogenesis of Laron Syndrome, an autosomal recessive hereditary disorder characterized by severe growth retardation. Biochemically, patients present normal to high circulating GH levels, in presence of very low or undetectable IGF-I levels, which do not rise after rhGH treatment. We describe the case of a 3.8 years old girl with symmetrical short stature (-3.76 SDS), low IGF-1 and IGFBP-3, in presence of normal GH levels. Parents were not relatives and there was no family history of short stature. During the second day of birth, she developed severe hypoglycaemia that required glucose infusion. She presented frontal bossing and depressed nasal bridge. IGF-1 generation test showed no response, suggesting a GH resistance evidence. In the hypothesis of Laron Syndrome, we decided to perform a molecular analysis of Growth Hormone Receptor (GHR) gene. This analysis demonstrated that the patient was compound heterozygote for two missense mutations. GHR gene mutations are a well demonstrated cause of GH insensitivity. In heterozygous patients, probably the normal stature may be achieved by a compensatory mechanism of GH secretion or signalling. On the contrary, in homozygous or compound heterozygous patients these compensatory mechanisms are inadequate, and short stature may be the consequence.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 059536612

Download citation: RISBibTeXText

PMID: 29025428

DOI: 10.1186/s13052-017-0411-7


Related references

Compound heterozygosity for two novel missense mutations in the prothrombin gene in a patient with a severe bleeding tendency. Thrombosis and Haemostasis 77(4): 610-615, 1997

Compound heterozygosity for missense mutations in the flavin-containing monooxygenase 3 (FM03) gene in patients with fish-odour syndrome. Pharmacogenetics 10(9): 799-807, 2001

Compound heterozygosity of two missense mutations in the NADH-cytochrome b5 reductase gene of a Polish patient with type I recessive congenital methaemoglobinaemia. European Journal of Haematology 70(6): 404-409, 2003

A child with macrocephaly: case report of a patient with megalencephalic leukoencephalopathy with subcortical cysts and a compound heterozygosity for two mutations in the MLC1 gene. Minerva Pediatrica 63(2): 125-129, 2011

Compound heterozygosity for a novel nine-nucleotide deletion and the Asn45Ser missense mutation in the glycoprotein IX gene in a patient with Bernard-Soulier syndrome. American Journal of Hematology 78(1): 41-48, 2004

Compound heterozygosity for 2 novel TMEM16F mutations in a patient with Scott syndrome. Blood 117(16): 4399-4400, 2011

Missense mutations in the growth hormone receptor dimerization region in Laron syndrome. American Journal of Human Genetics 55(3 SUPPL ): A212, 1994

Compound heterozygosity for factor V and methylenetetrahydrofolate reductase mutations in a patient with Budd-Chiari syndrome. Journal of Gastroenterology and Hepatology 21(4): 782-783, 2006

Compound heterozygosity for nonsense and missense mutations in the LAMB3 gene in nonlethal junctional epidermolysis bullosa. Journal Of Investigative Dermatology. 106(5): 1157-1159, 1996

Compound heterozygosity for missense mutations in the glycoprotein IB-beta gene associated with hereditary giant platelet disorder. Blood 86(10 SUPPL 1): 901A, 1995

Compound heterozygosity of novel missense mutations (Ser(45) -> Gly, CYS278 -> Arg) in the lipoprotein lipase gene in a newborn Korean infant. Clinica Chimica Acta 387(1-2): 172-174, 2008

Long term survival of a patient with Perlman syndrome due to novel compound heterozygous missense mutations in RNB domain of DIS3L2. American Journal of Medical Genetics. Part a 173(4): 1077-1081, 2017

Gaucher disease with prenatal onset and perinatal death due to compound heterozygosity for the missense R131C and null Rec Nci I GBA mutations. Pediatric and Developmental Pathology 14(3): 240-243, 2011

Compound heterozygosity of novel missense mutations (Ser45 --> Gly, Cys278 --> Arg) in the lipoprotein lipase gene in a newborn Korean infant. Clinica Chimica Acta; International Journal of Clinical Chemistry 387(1-2): 172-174, 2007

Two rare missense mutations in the fibrillin‑1 gene associated with atypical cardiovascular manifestations in a Chinese patient affected by Marfan syndrome. Molecular Medicine Reports 18(1): 877-881, 2018